MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).
| Outcome | beta | se | p | method | nSNP | cis/trans | coloc |
|---|---|---|---|---|---|---|---|
| Non-cancer illness code self-reported: hypothyroidism or myxoedema | -0.144 | 0.0332 | 1.43e-05 | Wald ratio | 1 | cis | NA |
| Lumbar spine bone mineral density | -0.076 | 0.0238 | 0.00143 | Wald ratio | 1 | cis | NA |
| Type 2 diabetes | 0.119 | 0.0393 | 0.00249 | Wald ratio | 1 | cis | NA |
| Schizophrenia | -0.0885 | 0.0294 | 0.00258 | Wald ratio | 1 | cis | NA |
| Hearing difficulty or problems: Yes | 0.0312 | 0.0108 | 0.00392 | Wald ratio | 1 | cis | NA |
| Happiness | -0.0218 | 0.00799 | 0.00646 | Wald ratio | 1 | cis | NA |
| Non-cancer illness code self-reported: anxiety or panic attacks | -0.177 | 0.0668 | 0.00813 | Wald ratio | 1 | cis | NA |
| Non-cancer illness code self-reported: uterine fibroids | 0.122 | 0.0463 | 0.00836 | Wald ratio | 1 | cis | NA |
| Diagnoses - main ICD10: G47 Sleep disorders | -0.286 | 0.114 | 0.012 | Wald ratio | 1 | cis | NA |
| Non-cancer illness code self-reported: depression | -0.0682 | 0.0285 | 0.0168 | Wald ratio | 1 | cis | NA |
| Fractured bone site(s): Other bones | 0.0629 | 0.0264 | 0.0173 | Wald ratio | 1 | cis | NA |
| Serum cystatin C (eGFRcys) | -0.012 | 0.0053 | 0.0233 | Wald ratio | 1 | cis | NA |
| …and 107 more outcomes (see JSON) |
No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).
No GWAS Catalog associations mapped to this gene.
Top diseases by Open Targets association (of 634 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.
| Disease | genetic assoc. | burden (ExWAS) | causal status | MR status |
|---|---|---|---|---|
| type 2 diabetes mellitus | 0.573 | — | common-variant locus | no MR -> candidate analysis |
| acne | 0.529 | — | common-variant locus | no MR -> candidate analysis |
| myeloid leukemia | 0.505 | — | common-variant locus | no MR -> candidate analysis |
| Abnormality of skin pigmentation | 0.473 | — | common-variant locus | no MR -> candidate analysis |
| hypothyroidism | 0.45 | — | common-variant locus | MR: beta=-0.144, p=1.43e-05 (cis) |
| myxedema | 0.386 | — | common-variant locus | no MR -> candidate analysis |
| atrial fibrillation | 0.356 | — | common-variant locus | no MR -> candidate analysis |
| ACPA-positive rheumatoid arthritis | 0.283 | — | common-variant locus | no MR -> candidate analysis |
| hemorrhagic disease | 0.273 | — | common-variant locus | no MR -> candidate analysis |
| hyperlipidemia | 0.254 | — | common-variant locus | no MR -> candidate analysis |
| Hypercholesterolemia | 0.252 | — | common-variant locus | MR: beta=-0.0188, p=0.176 (cis) |
| metabolic disease | 0.249 | — | common-variant locus | no MR -> candidate analysis |
| Abnormality of the skeletal system | 0.237 | — | common-variant locus | no MR -> candidate analysis |
| diabetes mellitus | 0.212 | — | common-variant locus | no MR -> candidate analysis |
| thrombocytopenia 4 | 0.207 | — | common-variant locus | no MR -> candidate analysis |
Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.
| Layer | Result |
|---|---|
| ChEMBL druggability | not available — no ChEMBL target (undrugged) |
| gnomAD constraint | pLI=2e-10, LOEUF=1.41 — LoF-tolerant |
| GWAS Catalog | 104 unique SNPs / 232 rows |
| ClinVar | 88 records; 2 pathogenic in sample of 30 |
| PharmGKB/ClinPGx | no annotations |
phenome — Top 30 of 634 associated diseases by overall score. genetic_association aggregates GWAS common-variant AND rare-variant evidence. These are ASSOCIATIONS (loci), not causal claims.chembl — No ChEMBL target for ‘TIMP4’.clinvar — Pathogenic count is over the 30 record(s) retrieved, NOT over all 88 ClinVar records for this gene; it is a sample, not a rate.pharmgkb — No PharmGKB/ClinPGx clinical annotations (gene may not be a pharmacogene).gwas_traits — No GWAS Catalog associations mapped to this gene.uniprot: https://www.uniprot.org/uniprotkb/Q99727 — UniProt release 2026_02 (10-June-2026)mr_outcomes: https://epigraphdb.org/pqtl/ — EpiGraphDB pQTL MR (Zheng et al., Nat Genet 2020) — pre-computed two-sample MR; retrieved, not computed by this agent; EpiGraphDB build 1.0, pQTL dataset v3.0phenome: https://platform.opentargets.org/target/ENSG00000157150/associations — Open Targets data release 26.06gnomad: https://gnomad.broadinstitute.org/gene/TIMP4 — gnomAD constraint via GraphQL API (reference genome GRCh38)gwas: https://www.ebi.ac.uk/gwas/genes/TIMP4 — GWAS Catalog REST (live; release not exposed by this endpoint)clinvar: https://www.ncbi.nlm.nih.gov/clinvar/?term=TIMP4%5Bgene%5D — ClinVar build Build260809-1055.1